Phase II Trial of Nivolumab Plus Ipilimumab in Patients With Renal Medullary Carcinoma

Clinical trial NCT03274258 · TERMINATED

Trial details

NCT number: NCT03274258
Sponsor: M.D. Anderson Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Kidney Medullary Carcinoma Loss of INI 1 Protein Expression Stage III Renal Cell Cancer AJCC v8 Stage IV Renal Cell Cancer AJCC v8

Start date: 2018-05-29
Primary completion: 2025-11-21
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.